A longitudinal study of cotinine in long-term daily users of e-cigarettes

Drug and Alcohol Dependence

Volumn 160, Issue , 2016, Pages 218-221

  Etter, Jean François ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cotinine; E cigarette; Electronic cigarette; Nicotine; Tobacco

Indexed keywords

COTININE; NICOTINE;

ADULT; ARTICLE; CONTROLLED STUDY; ELECTRONIC CIGARETTE; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; SALIVA LEVEL; SMOKING; SMOKING CESSATION; CHEMISTRY; FOLLOW UP; FRANCE; METABOLISM; MIDDLE AGED; PROCEDURES; SALIVA; SWITZERLAND; TIME FACTOR; TOBACCO USE DISORDER; UNITED STATES;

COTININE; ELECTRONIC CIGARETTES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NICOTINE; SALIVA; SMOKING; SMOKING CESSATION; SWITZERLAND; TIME FACTORS; TOBACCO USE DISORDER; UNITED STATES;

EID: 84960096291     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.01.003     Document Type: Article

References (32)

1. Adriaens K., Van Gucht D., Declerck P., Baeyens F. Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int. J. Environ. Res. Public Health 2014, 11:11220-11248.
2. Action on Smoking and Health, (ASH) Use of Electronic Cigarettes (vapourisers) Among Adults in Great Britain 2015, ASH, London, 1-9.
3. Benowitz N.L., Zevin S., Jacob P. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br. J. Clin. Pharmacol. 1997, 43:259-267.
4. Berg C.J., Barr D.B., Stratton E., Escoffery C., Kegler M. Attitudes toward e-cigarettes reasons for initiating e-cigarette use, and changes in smoking behavior after initiation: a pilot longitudinal study of regular cigarette smokers. Open J. Prev. Med. 2014, 4:789-800.
5. Bullen C., Howe C., Laugesen M., McRobbie H., Parag V., Williman J., Walker N. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013, 382:1629-1637.
6. Caponnetto P., Campagna D., Cibella F., Morjaria J.B., Caruso M., Russo C., Polosa R. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013, 8:e66317.
7. Dave, 2016. What is sub Ohm vaping? Our guide to sub Ohm vapes (airflow, big flavor and clouds). Vaping360com / (accessed 01.05.16). http://vaping360.com/what-is-sub-ohm-vaping-and-the-dangers-of-sub-ohm-vapes.
8. Delnevo C.D., Giovenco D.P., Steinberg M.B., Villanti A.C., Pearson J.L., Niaura R.S., Abrams D.B. Patterns of electronic cigarette use among adults in the United States. Nicotine Tob. Res. 2015, Epub ahead of print.
9. Douptcheva N., Etter J.F., Gmel G. Use of electronic cigarettes among young Swiss men. J. Epidemiol. Commun. Health 2013, 67:1075-1076.
10. El-Hellani A., El-Hage R., Baalbaki R., Salman R., Talih S., Shihadeh A., Saliba N.A. Free-base and protonated nicotine in electronic cigarette liquids and aerosols. Chem. Res. Toxicol. 2015, 28:1532-1537.
11. Etter J.F. Levels of saliva cotinine in electronic cigarette users. Addiction 2014, 109:825-829.
12. Etter, J.F., 2015. Characteristics of users, and usage of different types of electronic cigarettes: findings from an online survey. Addiction epub.
13. Etter J.F., Bullen C. Saliva cotinine levels in users of electronic cigarettes. Eur. Respir. J. 2011, 38:1219-1220.
14. Etter J.F., Neidhart E., Bertrand S., Malafosse A., Bertrand D. Collecting saliva by mail for genetic and cotinine analyses in participants recruited through the Internet. Eur. J. Epidemiol. 2005, 20:833-838.
15. Etter J.F., Perneger T.V., Ronchi A. Collecting saliva samples by mail. Am. J. Epidemiol. 1998, 147:141-146.
16. Etter J.F., Vu Duc T., Perneger T.V. Saliva cotinine levels in smokers and nonsmokers. Am. J. Epidemiol. 2000, 151:251-258.
17. Farsalinos K.E., Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Thera. Adv. Drug Safe. 2014, 5:67-86.
18. Gariti P., Alterman A.I., Barber W., Bedi N., Luck G., Cnaan A. Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting. Drug Alcohol Depend 1999, 54:111-116.
19. Gourlay S.G., Benowitz N.L., Forbes A., McNeil J.J. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment. Eur. J. Clin. Pharmacol. 1997, 51:407-414.
20. Kershaw, O., 2015. If E-Cigarettes Are So Great, How Come All Smokers Aren't Using Them? E-cigarette Summit, London, UK, 12 November 2015 . http://www.e-cigarette-summit.com/files/2015/11/1620-OliverKershaw.pdf.
21. Le Houezec J. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Int. J. Tuberc. Lung Dis. 2003, 7:811-819.
22. Machacek D.A., Jiang N.S. Quantification of cotinine in plasma and saliva by liquid chromatography. Clin. Chem. 1986, 32:979-982.
23. McNeill A., Etter J.F., Farsalinos K., Hajek P., le Houezec J., McRobbie H. A critique of a World Health Organization-commissioned report and associated paper on electronic cigarettes. Addiction 2014, 109:2128-2134.
24. McRobbie H., Phillips A., Goniewicz M.L., Smith K.M., Knight-West O., Przulj D., Hajek P. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine carbon monoxide, and acrolein. Cancer Prev. Res. (Phila.) 2015, 8:873-878.
25. Pacifici R., Pichini S., Graziano S., Pellegrini M., Massaro G., Beatrice F. Successful nicotine intake in medical assisted use of e-cigarettes: a pilot study. Int. J. Environ. Res. Public Health 2015, 12:7638-7646.
26. Regan A.K., Promoff G., Dube S.R., Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the 'e-cigarette' in the USA. Tob. Control 2013, 22:19-23.
27. Silla K., Beard E., Shahab L. Nicotine replacement therapy use among smokers and ex-smokers: associated attitudes and beliefs: a qualitative study. BMC Public Health 2014, 14:1311.
28. van Staden S.R., Groenewald M., Engelbrecht R., Becker P.J., Hazelhurst L.T. Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. S. Afr. Med. J. 2013, 103:865-868.
29. Vansickel A.R., Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob. Res 2013, 15:267-270.
30. Wall M.A., Johnson J., Jacob P., Benowitz N.L. Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am. J. Public Health 1988, 78:699-701.
31. Wang J., Etter J.F. Administering an effective health intervention for smoking cessation online: the international users of Stop-Tabac. Prev. Med 2004, 39:962-968.
32. Yates K. A content analysis of electronic cigarette portrayal in newspapers. Tob. Regul. Sci. 2015, 1:94-102.